HealthTree Logo
search more_vert
close
person Sign In / Create Account

Clinical Expertise

  • Myelodysplastic Syndromes

About

Dr. Elghetany has been studying the expression of the p53, p21 waf, WT-1, caspase-3, survivin, and Ki 67 in inherited and acquired bone marrow failure syndromes in an attempt to gain insight into the mechanism of cytopenias. Also, he is investigating the possible use of expression patterns to help differentiate inherited from acquired cytopenias. He continues to study patients with inherited bone marrow failure syndromes using cytochemistry and flow cytometry in order to find changes that could be predictive of the development of myelodysplastic syndrome or acute leukemia.

Location

Texas Children's Cancer Center: 1102 Bates Ave, Houston, TX 77030, USA

Get the latest thought leadership on Myelodysplastic Syndromes delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Myelodysplastic Syndromes Newsletter" for Myelodysplastic Syndromes news, life with Myelodysplastic Syndromes stories, Myelodysplastic Syndromes clinical trials, Myelodysplastic Syndromes 101 articles and events with Myelodysplastic Syndromes experts.

Thanks to our HealthTree Community for Myelodysplastic Syndromes Sponsors:

AbbVie
Bristol Myers Squibb

Follow Us

facebook instagram youtube